IL5 and allergic rhinitis: Additionally, in a double-blinded, randomized, placebo-controlled clinical trial, sulforaphane showed effects in decreasing T2 cytokines such as IL-4, IL-5, and IL-13 in nasal cavity mucus of allergic rhinitis patients [94].